It is the first injectable bone void filler in the U.S. to incorporate magnesium, and it isdesigned to treat insufficiency and microfractures, according to a Jan. 25 news release. Magnesium aids the bone’s absorption and regulation of calcium. Mg Osteoinject is resorbable and can assimilate back into the body during the healing process.
The injectable bone void filler is being distributed to healthcare facilities in the U.S., according to the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.